Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Friedlaender, A; Metro, G; Signorelli, D; Gili, A; Economopoulou, P; Roila, F; Banna, G; De Toma, A; Camerini, A; Christopoulou, A; Lo Russo, G; Banini, M; Galetta, D; Jimenez, B; Collazo-Lorduy, A; Calles, A; Baxevanos, P; Linardou, H; Kosmidis, P; Mountzios, G; Garassino, MC; Addeo, A.

Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score >= 50% treated with front-line pembrolizumab

ACTA ONCOLOGICA. 2020; 59(9): 1058-1063 Nº de citas: 35 [doi:10.1080/0284186X.2020.1781249]

Aviles-Izquierdo, JA; Nieto-Benito, LM; Lazaro-Ochaita, P; Escat-Cortes, JL; Marquez-Rodas, I; Mercader-Cidoncha, E.

Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution

Clinical & Translational Oncology. 2020; 22(9): 1611-1618 Nº de citas: 1 [doi:10.1007/s12094-020-02306-w]

Moran, T; Taus, A; Arriola, E; Aguado, C; Domine, M; Rueda, AG; Calles, A; Cedres, S; Vinolas, N; Isla, D; Palmero, R; Sereno, M; Diaz, V; Juan, O; Marse, R; Martorell, PM; Torres, JMS; Uncommon EGFR Mutations Spain.

Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study

Clinical Lung Cancer. 2020; 21(5): 428 Nº de citas: 22 [doi:10.1016/j.cllc.2020.04.011]

Martin, M; Guerrero-Zotano, A; Montero, A; Jara, C; Filipovich, E; Rojo, F; Moreno, F; Garcia-Saenz, JA; Ales, JE; Chacon, JI; Cruz, J; Gimenez, J; Cruz-Merino, L; Algara, M; Santisteban, M; Tarruella, SL.

GEICAMGuidelines for the Management of Patients with Breast Cancer During theCOVID-19 Pandemic in Spain

ONCOLOGIST. 2020; 25(9): 1339-1345 Nº de citas: 13 [doi:10.1634/theoncologist.2020-0363]

Sastre, J; de la Orden, V; Martinez, A; Bando, I; Balbin, M; Bellosillo, B; Palanca, S; Gomez, MIP; Mediero, B; Llovet, P; Moral, VM; Vieitez, JM; Garcia-Alfonso, P; Calle, SG; Ortiz-Morales, MJ; Salud, A; Quintero, G; Lopez, C; Diaz-Rubio, E; Aranda, E.

Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naive Metastatic Colorectal Cancer Patients Prospectively Collected

Clinical Colorectal Cancer. 2020; 19(3): 110-116 Nº de citas: 30 [doi:10.1016/j.clcc.2020.02.014]

Nunez-Torres, R; Martin, M; Garcia-Saenz, JA; Rodrigo-Faus, M; del Monte-Millan, M; Tejera-Perez, H; Pita, G; de la Torre-Montero, JC; Pinilla, K; Herraez, B; Peiro-Chova, L; Bermejo, B; Lluch, A; Gonzalez-Neira, A.

Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer

JAMA Dermatology. 2020; 156(9): 987-991 Nº de citas: 13 [doi:10.1001/jamadermatol.2020.1867]

Fernandez-Montes, A; Gravalos, C; Pericay, C; Safont, MJ; Benavides, M; EElez, E; Garcia-Alfonso, P; Garcia-Paredes, B; Carrato, A; Aranda, E.

Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion

Clinical Colorectal Cancer. 2020; 19(3): 165-177 Nº de citas: 21 [doi:10.1016/j.clcc.2020.04.003]

Escudero-Vilaplana, V; Collado-Borrell, R; Hoyo-Munoz, A; Gimenez-Manzorro, A; Calles, A; Osorio, S; Herranz-Alonso, A; Sanjurjo-Saez, M.

Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice

Expert Opinion On Drug Safety. 2020; 19(8): 1041-1048 Nº de citas: 12 [doi:10.1080/14740338.2020.1781089]

Carmona-Bayonas, A; Gomez, D; de Castro, EM; Segura, PP; Langa, JM; Jimenez-Fonseca, P; Canovas, MS; Moran, LO; Escobar, IG; Blanco, ABR; Perez, IF; de Prado, PM; Balanya, RPI; Verduguez, TQ; Rodriguez-Lescure, A; Munoz, A.

A snapshot of cancer-associated thromboembolic disease in 2018-2019: First data from the TESEO prospective registry

European Journal of Internal Medicine. 2020; 78: 41-49 Nº de citas: 32 [doi:10.1016/j.ejim.2020.05.031]

Camps Herrero, C; Batista, N; Diaz Fernandez, N; Escobar Alvarez, Y; Gonzalo Gomez, A; Isla Casado, D; Salud, A; Terrasa Pons, J; Guillem Porta, V.

Breakthrough cancer pain: review and calls to action to improve its management

Clinical & Translational Oncology. 2020; 22(8): 1216-1226 Nº de citas: 28 [doi:10.1007/s12094-019-02268-8]

Izquierdo, JAA; Lopez, IM; Morillo, PS; Rodas, IM; Cidoncha, EM.

Utility of PET/CT in patients with stage I-III melanoma

Clinical & Translational Oncology. 2020; 22(8): 1414-1417 Nº de citas: 8 [doi:10.1007/s12094-019-02252-2]

Vera, R; Gomez, ML; Ayuso, JR; Figueras, J; Garcia-Alfonso, P; Martinez, V; Lacasta, A; Ruiz-Casado, A; Safont, MJ; Aparicio, J; Campos, JM; Camara, JC; Martin-Richard, M; Montagut, C; Pericay, C; Vieitez, JM; Falco, E; Jorge, M; Marin, M; Salgado, M; Viudez, A.

Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study

Cancers. 2020; 12(8): Nº de citas: 9 [doi:10.3390/cancers12082259]

Galeano-Valle, F; Perez-Rus, G; Demelo-Rodriguez, P; Ordieres-Ortega, L; Ortega-Moran, L; Munoz-Martin, AJ; Medina-Molina, S; Alvarez-Sala-Walther, LA; del-Toro-Cervera, J.

Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin

Clinical & Translational Oncology. 2020; 22(8): 1312-1320 Nº de citas: 4 [doi:10.1007/s12094-019-02258-w]

Sanchis, AC; Gallego, J; Hernandez, R; Arrazubi, V; Custodio, A; Cano, JM; Aguado, G; Macias, I; Lopez, C; Lopez, F; Visa, L; Garrido, M; Lago, NM; Montes, AF; Limon, ML; Azkarate, A; Pimentel, P; Reguera, P; Ramchandani, A; Cacho, JD; Carnicero, AM; Granja, M; Richard, MM; Perez, CH; Hurtado, A; Serra, O; Buxo, E; Tocino, RV; Jimenez-Fonseca, P; Carmona-Bayonas, A.

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry

PLoS One. 2020; 15(7): Nº de citas: 22 [doi:10.1371/journal.pone.0235848]

Amor-Garcia, MA; Collado-Borrell, R; Escudero-Vilaplana, V; Melgarejo-Ortuno, A; Herranz-Alonso, A; Arija, JAA; Sanjurjo-Saez, M.

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis

JMIR mHealth and uHealth. 2020; 8(7): Nº de citas: 40 [doi:10.2196/17609]

Wainberg, ZA; Feeney, K; Lee, MA; Munoz, A; Gracian, AC; Lonardi, S; Ryoo, BY; Hung, AN; Lin, Y; Bendell, J; Hecht, JR.

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens

BMC CANCER. 2020; 20(1): Nº de citas: 29 [doi:10.1186/s12885-020-07110-x]

Paz-Ares, L; Kim, TM; Vicente, D; Felip, E; Lee, DH; Lee, KH; Lin, CC; Flor, MJ; Di Nicola, M; Alvarez, RM; Dussault, I; Helwig, C; Ojalvo, LS; Gulley, JL; Cho, BC.

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-beta and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial

JOURNAL OF THORACIC ONCOLOGY. 2020; 15(7): 1210-1222 Nº de citas: 172 [doi:10.1016/j.jtho.2020.03.003]

Trilla-Fuertes, L; Ghanem, I; Maurel, J; G-Pastrian, L; Mendiola, M; Pena, C; Lopez-Vacas, R; Prado-Vazquez, G; Lopez-Camacho, E; Zapater-Moros, A; Heredia, V; Cuatrecasas, M; Garcia-Alfonso, P; Capdevila, J; Conill, C; Garcia-Carbonero, R; Heath, KE; Ramos-Ruiz, R; Llorens, C; Campos-Barros, A; Gamez-Pozo, A; Feliu, J; Vara, JAF.

Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma

Translational Oncology. 2020; 13(7): Nº de citas: 9 [doi:10.1016/j.tranon.2020.100778]